Elaine W. Butterly

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality-Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns.

A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality-Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns.

Journal: Diabetes, obesity & metabolism
Published: November 17, 2025

Assessing the representativeness of trials of Sodium-glucose Cotransporter-2 inhibitors in type 2 diabetes: a comparison of individual-level trial data and people newly prescribed treatment in a Welsh routine care database.

Assessing the representativeness of trials of Sodium-glucose Cotransporter-2 inhibitors in type 2 diabetes: a comparison of individual-level trial data and people newly prescribed treatment in a Welsh routine care database.

Journal: BMC medicine
Published: August 13, 2025

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.

Journal: JAMA
Published: February 03, 2025

Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.

Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.

Journal: PLoS medicine
Published: September 12, 2024

Description of subgroup reporting in clinical trials of chronic diseases: a meta-epidemiological study.

Description of subgroup reporting in clinical trials of chronic diseases: a meta-epidemiological study.

Journal: BMJ open
Published: June 22, 2024

Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data.

Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data.

Journal: BMJ medicine
Published: August 17, 2023

Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis.

Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis.

Journal: Journal of multimorbidity and comorbidity
Published: April 26, 2023

Assessing Representativeness of Randomised Controlled Trials using Serious Adverse Events.

Assessing Representativeness of Randomised Controlled Trials using Serious Adverse Events.

Journal: Annals of family medicine
Published: March 27, 2023

Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials.

Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials.

Journal: PLoS medicine
Published: January 06, 2023

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.

Journal: BMJ open
Published: October 27, 2022

Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.

Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.

Journal: PLoS medicine
Published: June 24, 2022

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.

Journal: BMC medicine
Published: April 26, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026